ISTH Appoints a New CEO
International Society on Thrombosis and Haemostasis (ISTH) shared a post on LinkedIn:
“News: We’re excited to announce Vishakha K. Kumar, as the new Executive Director/CEO of the International Society on Thrombosis and Haemostasis!
With more than 15 years of leadership experience across non-profit medical associations, healthcare, corporate and philanthropic organizations, Dr. Kumar brings a wealth of expertise to guide the Society’s next chapter of global growth and impact.
Working closely with the ISTH Council and staff, Dr. Kumar will help advance the Society’s strategic priorities while strengthening its commitment to serving the global thrombosis and hemostasis community through science, education and collaboration.
‘I am honored to join the ISTH and serve a global community that is making an extraordinary impact on patient care through science, education and collaboration. I look forward to building on the Society’s strong foundation to expand our global reach and create new opportunities to support innovation and education.’ — Vishakha K. Kumar.
Please join us in welcoming Dr. Kumar to the ISTH as we look ahead to an exciting future for our global community!”
Other posts about International Society on Thrombosis and Haemostasison Hemostasis Today.
-
Sep 9, 2026, 05:52Faheema Hasan: New ASH 2026 Guidelines Redefine Initial and Second-Line ITP Therapy
-
Sep 9, 2026, 05:43Thomas Pincez: Clonal Hematopoiesis Linked to Increased Risk of Autoimmune Hemolytic Anemia
-
Sep 9, 2026, 05:33Marianne Yee: Sickle Cell Disease and the Human Side of Medical Research
-
Sep 8, 2026, 16:14Heghine Khachatryan: Colombo 2026 Insights on Point-of-Care Ultrasound in Hemophilia Joint Care
-
Sep 8, 2026, 15:57Flora Peyvandi: Efficiency Meets Innovation in Hemophilia B Gene Therapy
-
Sep 8, 2026, 15:48Maxime Dely: Guillain-Barré Syndrome – What if the Key Lies in the Plasma?
-
Sep 8, 2026, 15:34Ron DePinho: A Negative Trial Highlights the Need for Precision in Cardiovascular Inflammation
-
Sep 8, 2026, 15:31Adil Yousaf: Thrombolysis Speed Matters, but Eligibility Comes First
-
Sep 8, 2026, 15:28Dhargam Aljebouri: First Molecularly Characterized Para-Bombay Phenotype in the Arab World